Results 161 to 170 of about 113,618,068 (200)

Cancer Antigen CA 15-3 Levels in Breast Cancer Patients

International Journal of Research and Scientific Innovation
Background; Breast cancer is a disease in which certain cells become abnormal and develop abnormally and become tumors in the breast. Research method: the method used is descriptive by looking at the CA 15-3 level values ​​before and after breast cancer surgery.
Muhammad Basirun, Umi Aminatul Qirom, Dadi Santoso, Eka Riyanti, Nurlaela Ela, Sawiji Amani   +5 more
openaire   +1 more source

Determination of carcinoembryonic antigen and cancer antigen (CA 15‐3) in bitches with tumours on mammary gland: preliminary report

Veterinary and Comparative Oncology, 2012
AbstractThe aim of this work was to determine levels of carcinoembryonic antigen (CEA) and cancer antigen (CA 15‐3) in the blood serum of 45 bitches. A modified procedure was used to determine the CEA and CA 15‐3 markers with the human kits using the radioimmunoassay method. Samples collected from extirpated tumour of mammary glands were histologically
A, Valencakova-Agyagosova, Z, Frischova, Z, Sevcikova, J, Hajurka, J, Lepej, I, Szakallova, G, Kredatusova, V, Nagy, V, Ledecky   +8 more
openaire   +2 more sources

Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer

Luminescence, 2000
Vascular endothelial growth factor (VEGF), tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) were measured in 314 sera of breast cancer patients and in 58 sera of women without breast cancer. VEGF was determined using a sandwich enzyme immunoassay technique (ELISA) and the tumour markers TPA, CA 15-3 and
R, Findeisen, S, Albrecht, B, Richter, K, Deutschmann, T, Zimmermann, W, Distler   +5 more
openaire   +2 more sources

[Level of CA 15-3 antigen--a prognostic factor in patients with breast cancer?].

Przeglad lekarski, 1997
Serum CA 15-3 concentrations were determined using sandwich enzyme immunoassay in 430 women: 214 breast cancer patients prior to any therapy, 161 patients with benign breast diseases, and 55 healthy controls; the cut-off limit was established at 30.0 U/ml. In breast cancer patients, CA 15-3 levels positively correlated with negative prognostic factors:
J, Wojtacki, A, Dziewulska-Bokiniec, D M, Kowalski, A, Zółtowska, D, Ciesielski, M, Suszko   +5 more
openaire   +1 more source

Can a cancer antigen (CA)15-3 directed monitoring strategy be resource sparing in metastatic breast cancer (MBC)?

Journal of Clinical Oncology, 2018
e13104Background: Serial monitoring of CA 15-3 levels can be used as a marker of disease activity in MBC. But the utility over and above image based monitoring remains controversial.
Santam Chakraborty, Chandran Nallathambi, Subhosmito Chakraborty, Ishita Ghatak, Sandip Ganguly, Joydeep Ghosh, Rosina Ahmed, Sanjit Agrawal, Sanjoy Chatterjee   +8 more
openaire   +1 more source

Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System

Clinical Biochemistry, 2011
We examined analytical characteristics of new CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen (CEA), and Alpha-Fetoprotein (AFP) assays on the Dimension Vista® System.Imprecision studies used CLSI-EP5-A2, Limit of Blank and Limit of Detection used CLSI-EP17 and measurement ranges were determined.
Robert H, Christenson, Denise R, Cervelli, Jamie, Sterner, Lauren M, Bachmann, Heather, Rebuck, Jeffery, Gray, Walter E, Kelley   +6 more
openaire   +2 more sources

A profile of serum CA 15‐3, carcinoembryonic antigen, alkaline phosphatase, and γ‐glutamyl transferase levels in patients with breast cancer

Journal of Surgical Oncology, 1993
AbstractThe CA 15‐3 and CEA concentrations and the alkaline phosphatase (ALP) and ‐γ‐glutamyl transferase (Gamma GT) activities of serum from 78 patients with breast cancer have been measured. The patients included 27 with localised breast cancer, 19 who had been treated for breast cancer but were now disease‐free, 17 with liver metastases, 8 with bone
P K, Buamah, D J, Bent, W A, Bodger, A W, Skillen   +3 more
openaire   +2 more sources

Role of Preoperative Plasma CA 15‐3 and Carcinoembryonic Antigen Levels in Determining Histopathologic Conventional Prognostic Factors for Breast Cancer

World Journal of Surgery, 2003
AbstractBreast cancer is one of the leading causes of cancer death among women all over the world, with about one million new breast cancer cases diagnosed per year. This large number of cases make the diagnosis, treatment, and determination of the factors affecting the survey extremely important. The aim of this study was to evaluate the importance of
Duray, Seker, Oskay, Kaya, Aysegul, Adabag, Gaye, Necipoglu, Ismet, Baran   +4 more
openaire   +2 more sources

[Evaluation of a tumor-associated antigen CA 15-3 in the sera of patients with breast cancer].

Gan no rinsho. Japan journal of cancer clinics, 1986
Serum levels of CA 15-3 were determined in normal women and patients with breast cancer and other diseases. The serum concentration of normal subjects was 9.8 +/- 4.4 units/ml (mean +/- S.D., n = 97). The patients with primary and recurrent breast cancer had significantly higher levels of CA 15-3, their values being 23.1 +/- 59.6 (n = 47) and 127.6 +/-
T, Ogawa, M, Izuo, H, Morita, T, Ishida, Y, Iino, K, Hoshino, T, Yokoe, H, Suzuki, S, Murata, S, Matsuzaki   +9 more
openaire   +1 more source

Preoperative Sensitivity and Specificity for Early-Stage Ovarian Cancer When Combining Cancer Antigen CA-125II, CA 15-3, CA 72-4, and Macrophage Colony-Stimulating Factor Using Mixtures of Multivariate Normal Distributions

Journal of Clinical Oncology, 2004
Purpose In CA-125–based ovarian cancer screening trials, overall specificity and screening sensitivity of ultrasound after an elevated CA-125 exceeded 99.6% and 70%, respectively, thereby yielding a positive predictive value (PPV) exceeding 10%. However, sensitivity for early-stage disease was only 40%.
Skates, S.J., Horick, N., Yu, Y.H., Xu, F.J., Berchuck, A., Havrilesky, L.J., de Bruijn, H.W.A., van der Zee, A.G.J., Woolas, R.P., Jacobs, I.J., Zhang, 27727, Bast, R.C., Zhang, Z   +12 more
openaire   +3 more sources